Lipocine has announced the completion of enrolment and participant dosing in its Phase III clinical trial investigating LPCN ...
FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...
The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.
The consensus statement affirms that lifestyle interventions—optimal nutrition, physical activity, restorative sleep, stress management, connectedness, and avoidance of risky substances—are integral ...
Nitrous oxide, informally known as laughing gas, has shown rapid antidepressant effects in people with depression in a series ...
Depression is not only a disorder of mood but also a condition that affects the heart and blood vessels, and can carry ...
Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...
Health and Me on MSN
Schizophrenia and bipolar disorder have the same genetic links, study finds
Researchers from across China have discovered that schizophrenia (SCZ), bipolar disorder (BD) and major depressive disorder, ...
Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise ...
The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...
Researchers from Hiroshima University in Japan and collaborating institutions have found that adults with asthma who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback